- call +1-201-465-4211
- email sales@mrinsights.biz
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Scope of the Report:
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.
The worldwide market for Radiopharmaceutical is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 8120 million US$ in 2024, from 4940 million US$ in 2019, according to a new study.
This report focuses on the Radiopharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market Segment by Applications, can be divided into
Oncology
Cardiology
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales, revenue and global market share of Radiopharmaceutical in 2017 and 2018.
Chapter 3, the Radiopharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Business Overview
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mallinckrodt
2.3.1 Business Overview
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Nordion
2.4.1 Business Overview
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Triad Isotopes
2.5.1 Business Overview
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lantheus
2.6.1 Business Overview
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 IBA Group
2.7.1 Business Overview
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 China Isotope & Radiation
2.9.1 Business Overview
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Jubilant Pharma
2.10.1 Business Overview
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Advanced Accelerator Applications
2.12.1 Business Overview
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 SIEMENS
2.13.1 Business Overview
2.13.2 Radiopharmaceutical Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Dongcheng
2.14.1 Business Overview
2.14.2 Radiopharmaceutical Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Navidea
2.15.1 Business Overview
2.15.2 Radiopharmaceutical Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Radiopharmaceutical Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceutical Manufacturer Market Share in 2018
3.3.2 Top 6 Radiopharmaceutical Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Radiopharmaceutical Market Analysis by Regions
4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceutical Sales and Market Share by Regions (2014-2019)
4.1.2 Global Radiopharmaceutical Revenue and Market Share by Regions (2014-2019)
4.2 North America Radiopharmaceutical Sales and Growth Rate (2014-2019)
4.3 Europe Radiopharmaceutical Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2014-2019)
4.5 South America Radiopharmaceutical Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2014-2019)
5 North America Radiopharmaceutical by Country
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceutical Sales and Market Share by Country (2014-2019)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Country (2014-2019)
5.2 United States Radiopharmaceutical Sales and Growth Rate (2014-2019)
5.3 Canada Radiopharmaceutical Sales and Growth Rate (2014-2019)
5.4 Mexico Radiopharmaceutical Sales and Growth Rate (2014-2019)
6 Europe Radiopharmaceutical by Country
6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceutical Sales and Market Share by Country (2014-2019)
6.1.2 Europe Radiopharmaceutical Revenue and Market Share by Country (2014-2019)
6.2 Germany Radiopharmaceutical Sales and Growth Rate (2014-2019)
6.3 UK Radiopharmaceutical Sales and Growth Rate (2014-2019)
6.4 France Radiopharmaceutical Sales and Growth Rate (2014-2019)
6.5 Russia Radiopharmaceutical Sales and Growth Rate (2014-2019)
6.6 Italy Radiopharmaceutical Sales and Growth Rate (2014-2019)
7 Asia-Pacific Radiopharmaceutical by Country
7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Radiopharmaceutical Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Radiopharmaceutical Revenue and Market Share by Country (2014-2019)
7.2 China Radiopharmaceutical Sales and Growth Rate (2014-2019)
7.3 Japan Radiopharmaceutical Sales and Growth Rate (2014-2019)
7.4 Korea Radiopharmaceutical Sales and Growth Rate (2014-2019)
7.5 India Radiopharmaceutical Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2014-2019)
8 South America Radiopharmaceutical by Country
8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceutical Sales and Market Share by Country (2014-2019)
8.1.2 South America Radiopharmaceutical Revenue and Market Share by Country (2014-2019)
8.2 Brazil Radiopharmaceutical Sales and Growth Rate (2014-2019)
8.3 Argentina Radiopharmaceutical Sales and Growth Rate (2014-2019)
8.4 Colombia Radiopharmaceutical Sales and Growth Rate (2014-2019)
9 Middle East and Africa Radiopharmaceutical by Countries
9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Radiopharmaceutical Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2014-2019)
9.3 Turkey Radiopharmaceutical Sales and Growth Rate (2014-2019)
9.4 Egypt Radiopharmaceutical Sales and Growth Rate (2014-2019)
9.5 Nigeria Radiopharmaceutical Sales and Growth Rate (2014-2019)
9.6 South Africa Radiopharmaceutical Sales and Growth Rate (2014-2019)
10 Global Radiopharmaceutical Market Segment by Type
10.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Radiopharmaceutical Sales and Market Share by Type (2014-2019)
10.1.2 Global Radiopharmaceutical Revenue and Market Share by Type (2014-2019)
10.2 Actinium-225 Sales Growth and Price
10.2.1 Global Actinium-225 Sales Growth (2014-2019)
10.2.2 Global Actinium-225 Price (2014-2019)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2014-2019)
10.3.2 Global Lutetium-177 Price (2014-2019)
10.4 Radium-223 Sales Growth and Price
10.4.1 Global Radium-223 Sales Growth (2014-2019)
10.4.2 Global Radium-223 Price (2014-2019)
10.5 Holmium-166 Sales Growth and Price
10.5.1 Global Holmium-166 Sales Growth (2014-2019)
10.5.2 Global Holmium-166 Price (2014-2019)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2014-2019)
10.6.2 Global Other Price (2014-2019)
11 Global Radiopharmaceutical Market Segment by Application
11.1 Global Radiopharmaceutical Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Cardiology Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Radiopharmaceutical Market Forecast (2019-2024)
12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2019-2024)
12.2 Radiopharmaceutical Market Forecast by Regions (2019-2024)
12.2.1 North America Radiopharmaceutical Market Forecast (2019-2024)
12.2.2 Europe Radiopharmaceutical Market Forecast (2019-2024)
12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2019-2024)
12.2.4 South America Radiopharmaceutical Market Forecast (2019-2024)
12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2019-2024)
12.3 Radiopharmaceutical Market Forecast by Type (2019-2024)
12.3.1 Global Radiopharmaceutical Sales Forecast by Type (2019-2024)
12.3.2 Global Radiopharmaceutical Market Share Forecast by Type (2019-2024)
12.4 Radiopharmaceutical Market Forecast by Application (2019-2024)
12.4.1 Global Radiopharmaceutical Sales Forecast by Application (2019-2024)
12.4.2 Global Radiopharmaceutical Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Radiopharmaceutical Picture
Table Product Specifications of Radiopharmaceutical
Figure Global Sales Market Share of Radiopharmaceutical by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
